You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH):收到藥品註冊申請終止通知書
格隆匯 07-18 17:21

格隆匯7月18日丨天士力(600535.SH)公佈,公司於2024年1月向國家藥品監督管理局(簡稱“國家藥監局”)藥品審評中心遞交枇杷清肺飲顆粒藥品註冊申請並獲得受理。現因該藥品需進一步完善申報資料,公司向國家藥監局提交了撤回藥品註冊申請,待完成補充研究後將重新遞交藥品註冊申請。公司於近日收到國家藥監局同意撤回註冊申請的《藥品註冊申請終止通知書》。

本次申請撤回藥品註冊申請不會對公司當期及未來生產經營與業績產生重大影響。由於醫藥產品具有高科技、高風險、高附加值的特點,藥品的前期研發以及產品從研製、申報到投產的週期長、環節多,容易受到技術、審批、政策等諸多因素影響。公司將密切關注該藥品研發事項的後續進展情況,及時履行信息披露義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account